3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pain, Postoperative
6
Pancreatic Neoplasms
5
Colorectal Neoplasms
4
Rectal Neoplasms
3
Colonic Neoplasms
3
Agnosia
3
Liver Neoplasms
2
Stomach Neoplasms
1
Pain
1
Neuralgia
1
Neoplasms
1
Intestinal Perforation
1
Intestinal Diseases
1
Inflammatory Bowel Diseases
1
Ileus
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Duodenal Neoplasms
1
Diverticulosis, Colonic
1
Diverticulitis, Colonic
1
Diverticulitis
1
Digestive System Diseases
1
Crohn Disease
1
Constipation
1
Interventions
Irinotecan
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Oxaliplatin
4
Fluorouracil
4
Capecitabine
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
napabucasin
3
Ocoxin
3
Leucovorin
3
pembrolizumab
2
Sorafenib
2
Paclitaxel
2
Nivolumab
2
Drug Therapy
2
Cyclophosphamide
2
Colonoscopy
2
Cetuximab
2
Aspirin
2
Ascorbic Acid
2
trifluridine tipiracil drug combination
1
trametinib
1
pralsetinib
1
penpulimab
1
lutetium Lu 177 dotatate
1
linifanib
1
halofantrine
1
guadecitabine
1
golotimod
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Diseases
×
Bupivacaine
×
Gastrointestinal
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts